Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients

doi:10.4239/wjd.v13.i7.532

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3855)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-7) series.

Item

Count

PDF

190

WORD

127

HTML

1753

Figures (1-2)

407

Tables (1-7)

339

Sum=2816

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

320

Download

719

Sum=1039

Jul 15, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Jul 15, 2022; 13(7): 532-542
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532

Full Size Figure Download Figure

Figure 1 Histogram of clinical efficiency and incidence of adverse reaction between the two groups. A: Histogram of clinical efficiency; B: Incidence of adverse reaction.

Citation: Li YF, Ren Q, Sun CH, Li L, Lian HD, Sun RX, Su X, Yu H. Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients. World J Diabetes 2022; 13(7): 532-542
URL: https://www.wjgnet.com/1948-9358/full/v13/i7/532.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i7.532